Boehringer Ingelheim Chairman von Baumbach Highlights Strong H1 2024 Performance and Pipeline Milestones

Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncology Further data read-outs expected in 2024 in oncology, mental health, ...

July 18, 2024 | Thursday | News
GC Cell and Checkpoint Therapeutics Announce Collaboration to Explore Synergistic Cancer Therapies

Collaboration explores the potential synergistic effects of Checkpoint’s anti-PD-L1, cosibelimab, in combination with the autologous T cell thera...

July 16, 2024 | Tuesday | News
China's NMPA Approves First and Only Subcutaneous FcRn Blocker for gMG Patients

First and only NMPA-approved subcutaneous injectable FcRn blocker for gMG patients in China Consistent clinical benefit and safety profile of efgartigim...

July 16, 2024 | Tuesday | News
AstraZeneca Completes Acquisition of Amolyt Pharma for $1.05 Billion

  Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related di...

July 15, 2024 | Monday | News
Rznomics Inc. Receives Approval for Phase 1/2a Clinical Trial of RZ-004 in Australia

Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, announced that it has receive...

July 15, 2024 | Monday | News
Taiwan's Senhwa Biosciences Submits IND to US FDA for Phase I/II Study of Silmitasertib in Pediatric Cancer Treatment

  Senhwa Biosciences, Inc. (TPEx: 6492), announced IND Submission to US FDA for the Phase I/II study of Silmitasertib (CX-4945) in combination with c...

July 12, 2024 | Friday | News
Thermo Fisher Scientific to Advance Myeloid Cancer Research with Next-Generation Sequencing Technology

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is proud to announce its partnership with the National Cancer Institute (...

July 12, 2024 | Friday | News
Pfizer's New Once-Daily Danuglipron Formulation Shows Promising Pharmacokinetic Results

Clinical evaluation of several modified release once-daily formulations of danuglipron resulted in encouraging pharmacokinetic data for several candi...

July 12, 2024 | Friday | News
Merck KGaA, Darmstadt, Germany Awards €500,000 Research Grant to Professor Lauren Gardner for AI-Based Pandemic Prevention Solutions

Award is a research grant of 500.000 € for AI-based solutions to prevent future pandemics Merck KGaA, Darmstadt, Germany CEO Belén Garijo ...

July 11, 2024 | Thursday | News
BioArctic AB’s Partner Eisai Announces Approval of Leqembi® (樂意保®) for Alzheimer’s Disease Treatment in Hong Kong

BioArctic AB  is pleased to announce that its partner, Eisai, has received approval from the Department of Health in Hong Kong for Leqembi® (bra...

July 11, 2024 | Thursday | News
Daiichi Sankyo Expands European Presence with New Oncology Affiliate in Greece

Daiichi Sankyo  announced that it has opened a new affiliate for its oncology business in Athens, Greece. The establishment highlights the company&r...

July 10, 2024 | Wednesday | News
HepaRegeniX Secures €15M Series C Funding to Advance Liver Regeneration Therapy HRX-215

Funds to support Phase Ib clinical trial of HRX-215 in the US and an international multicenter Phase IIa clinical trial in liver regeneration Elias Pa...

July 10, 2024 | Wednesday | News
Apriori Bio Secures $1.1 Million from CEPI to Enhance AI-Driven Vaccine Platform Against Evolving Viruses

Biotechnology company Apriori Bio has been awarded US $1.1 million from CEPI to advance its biology-informed artificial intelligence platform Octavi...

July 09, 2024 | Tuesday | News
Boehringer Ingelheim and OSE Immunotherapeutics Advance SIRPα Immuno-Oncology Program to Phase 1b Clinical Trials

Boehringer Ingelheim and OSE Immunotherapeutics SA (OSE), a clinical stage biotech company (ISIN: FR0012127173; Mnemo: OSE), announced that Boehringer wi...

July 04, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in